Bishal Gyawali: ASCO Guidelines Shaped Me - Now I Help Shape What’s Next
CheckMate 743 Five-Year Update: Nivolumab Plus Ipilimumab Maintains Long-Term Survival Benefit in Unresectable Pleural Mesothelioma
Neeraj Agarwal on ASCO GU 2026: Survival Signals, Biomarkers, and the Future of GU Trials Part 1
10 Oncology Specialists Join OncoDaily Medical Journal’s Editorial Team
Margaret Foti: Grateful to Congress for Supporting NIH and NCI
Scott Kopetz: FDA Grants Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line mCRC
Deepti Sharma: A Global Collaborative Forum on Cancer Care
Susanna Fletcher Greer: Stories Like This Beautiful One Stay With Me
